This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Extend Biosciences, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Ahmet Vakkasoglu: Innovator in Long-Acting Parathyroid Hormone
Introduction
Ahmet Vakkasoglu is a notable inventor based in Stoneham, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of long-acting parathyroid hormone peptides. His innovative work has the potential to greatly impact medical treatments related to calcium regulation in the body.
Latest Patents
Vakkasoglu holds a patent for a long-acting parathyroid hormone peptide. This invention provides a peptide that is retained in a subject's blood serum for extended periods, far exceeding the natural hormone's duration. The long-acting PTH is conjugated to a non-hormonal vitamin D at the carbon 3 position, utilizing a scaffold that enhances purification, detection, solubility, and efficacy at the PTH receptor. The specific formulation, PTH-PEG36-VitD, demonstrates a vastly improved serum half-life and bioavailability compared to non-conjugated PTH peptides. This innovative peptide significantly increases serum calcium levels, reduces urinary calcium, and lowers serum phosphate.
Career Highlights
Vakkasoglu is associated with Extend Biosciences, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic options for patients requiring hormone regulation.
Collaborations
He collaborates with esteemed colleagues such as Poul Strange and Daniel B Hall, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Ahmet Vakkasoglu's contributions to the field of biochemistry, particularly through his patent for long-acting parathyroid hormone, exemplify the impact of innovative thinking in medicine. His work at Extend Biosciences, Inc. continues to pave the way for advancements in hormone therapy.